← Eichor
Study identifier: NCT07169643 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)

Condition: Liver Transplant; Complications  ·  Sponsor: Fundacion Clinic per a la Recerca Biomédica

PhasePhase 3
Planned participants140
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This is a national multicenter, randomized clinical trial to evaluate the the efficacy and safety of DP administration in patients on the liver transplant waiting list to reduce intraoperative red blood cell concentrate transfusion.

This description comes directly from the study's public registry record.

Talk to the study team

Anna cruceta, Dr  ·  +93 2275400  ·  acruceta@recerca.clinic.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Clinic de BarcelonaBarcelona, Catalonia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07169643